Navigation Links
Antigen


An antigen is any molecule that is recognized by antibodies. Usually, an antigen is a protein or a polysaccharide, but it can be any type of molecule, even small molecules if coupled to a large carrier (haptens).


There are several kinds of antigens:

  • Immunogen - Any substance that provokes an immune response (provokes immunity) when introduced into the body. An immunogen is always a macromolecule (protein, polysaccharide). Its ability to provoke the immune response depends on its foreignness to the host, molecular size, chemical composition and heterogeneity (e.g. different amino acids in a protein).
  • Tolerogen - An antigen that invokes a specific immune unresponsiveness due to its molecular form . A tolerogen can become an immunogen if its molecular form is changed.
  • Allergen - An allergen is any substance that causes an allergic reaction. It can be eaten, inhaled, injected or comes into contact with skin.

Antigens are presented by a cell to its environment via a histocompatibility molecule. Depending on the antigen presented and the histocompatibility molecule used, several types of immune cells can leap into action.

We can also classify antigens according to where they come from:

  • Exogenous antigens

Exogenous antigens are antigens that have entered the body, e.g., by inhalation, ingestion, or injection. These antigens are taken up by endocytosis or phagocytosis into the antigen presenting cells (APCs), and degraded into fragments. The fragments are then presented on the surface of APCs by class II histocompatibility molecules to T helper cells (CD4+). Those that are specific for them, get activated, so they start to secrete cytokines. The cytokines then activate cytotoxic lymphocytes T (CTL), antibodies secreting lymphocytes B , macrophages and other cells.

  • Endogenous antigens

Endogenous antigens are antigens that have been generated within the cell, as a result of normal cell metabolism, or because of viral or intracellular bacterial infection. The fragments are then presented on the cell surface in the complex with class I histocompatibility molecules. If cytotoxic CD8+ T cells recognize them, they begin to secrete different toxins that cause the lysis or apoptosis of the infected cell. In order to keep the cytotoxic cells from killing cells just for presenting normal proteins, they run through a test cycle (negative control in the thymus) just after their production. Only those CTL that do not react to normal body protein fragments are allowed to enter the bloodstream.


'"/>


(Date:12/3/2014)... Ariz. , Dec. 2, 2014 As ... hand readers, Inception Technologies is pleased to announce the ... easier for customers to collect the workforce data that ... problems that have been left by existing readers. Many ... user interface, connectivity and modern technology. Older models force ...
(Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, ... the Internet of Things (IoT), today announced the appointment ... chief operating officer. Previously a strategic advisor to the ... and operations. Mr. Traynor is based out of the ... He reports to Chris Muench , Chief Executive ...
(Date:11/18/2014)... 17, 2014 The Parenteral Drug Association (PDA) today ... will speak and at least seven more will participate in ... Omni Shoreham Hotel in Washington D.C. , ... have significant support from the regulatory agencies in ... in our effort to help advance the use of ...
Breaking Biology News(10 mins):Inception Technologies to Release New Biometric Reader 2C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... University researchers is examining a new vaccine method that ... Wannemuehler and his team of researchers is hoping to ... use smaller doses and require only one trip to ... been prepared from killed bacteria. The vaccinated person,s immune ...
... available in French . A ... McGill Universitys Department of Microbiology and Immunology has discovered ... regulate the bodys autoimmune reactions may lose their effectiveness ... of type 1 diabetes. The study conducted on ...
... 2008 The Rwandan government, Great Ape Trust of ... Reserve is the future site of the Rwanda National ... ambitious forest restoration and ecological research efforts ever. The ... national conservation park comes less than three months after ...
Cached Biology News:Iowa State researchers look for smaller, cheaper, 1-dose vaccines 2Type 1 diabetes triggered by 'lazy' regulatory T-cells: McGill researchers 2Rwanda's Gishwati Forest selected as site for historic conservation project 2Rwanda's Gishwati Forest selected as site for historic conservation project 3
Other biology definitionOther Tags